Vitamin K1 antagonisation is not safe in high thromboembolic risk patients with over-anticoagulation.
We report a case of a fatal massive anterior acute myocardial infarction (AMI) after administration of vitamin K1 for over-anticoagulation following cardioembolism from mechanical mitroaortic valve prostheses associated with atrial fibrillation.